What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Myocardial infarction
His scientific interests lie mostly in Internal medicine, Cardiology, Myocardial infarction, Surgery and Coronary artery disease.
His Cardiology research is multidisciplinary, relying on both Prospective cohort study, Proportional hazards model and Disease.
His Myocardial infarction research focuses on subjects like Coronary arteries, which are linked to Streptokinase.
Daniel B. Mark interconnects Aspirin, Revascularization and Confidence interval in the investigation of issues within Surgery.
His Coronary artery disease research incorporates themes from Artery, Heart catheterization, Stenosis, Referral and Depression.
The study incorporates disciplines such as Heart disease and Sudden death in addition to Heart failure.
His most cited work include:
- MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS (6562 citations)
- Amiodarone or an implantable cardioverter-defibrillator for congestive Heart failure (5062 citations)
- ACC/AHA 2002 Guideline Update for Exercise Testing: Summary Article A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines) (2343 citations)
What are the main themes of his work throughout his whole career to date?
Daniel B. Mark focuses on Internal medicine, Cardiology, Myocardial infarction, Coronary artery disease and Surgery.
Heart failure, Ejection fraction, Angina, Revascularization and Randomized controlled trial are the primary areas of interest in his Internal medicine study.
His biological study spans a wide range of topics, including Sudden death, Implantable cardioverter-defibrillator, Intensive care medicine, Heart disease and Sudden cardiac death.
As part of one scientific family, he deals mainly with the area of Cardiology, narrowing it down to issues related to the Hazard ratio, and often Clinical endpoint.
His study in Myocardial infarction is interdisciplinary in nature, drawing from both Stroke and Emergency medicine.
His Coronary artery disease research includes elements of Stenosis, Radiology, Proportional hazards model, Chest pain and Physical therapy.
He most often published in these fields:
- Internal medicine (61.37%)
- Cardiology (49.27%)
- Myocardial infarction (28.13%)
What were the highlights of his more recent work (between 2013-2021)?
- Internal medicine (61.37%)
- Cardiology (49.27%)
- Heart failure (23.76%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Cardiology, Heart failure, Coronary artery disease and Chest pain are his primary areas of study.
His Internal medicine study focuses mostly on Hazard ratio, Ejection fraction, Myocardial infarction, Randomized controlled trial and Angina.
His Myocardial infarction research is multidisciplinary, incorporating perspectives in Stress testing and Adverse effect.
His research investigates the link between Cardiology and topics such as Interquartile range that cross with problems in Cohort study.
Daniel B. Mark combines subjects such as Implantable cardioverter-defibrillator, Clinical trial, Sudden cardiac death and Palliative care with his study of Heart failure.
His Coronary artery disease research is multidisciplinary, incorporating elements of Computed tomography angiography, Radiology, Stenosis, Revascularization and Physical therapy.
Between 2013 and 2021, his most popular works were:
- Outcomes of Anatomical versus Functional Testing for Coronary Artery Disease (763 citations)
- Initial invasive or conservative strategy for stable coronary disease. (390 citations)
- Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial. (352 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Myocardial infarction
Daniel B. Mark mainly investigates Internal medicine, Cardiology, Heart failure, Randomized controlled trial and Coronary artery disease.
His works in Hazard ratio, Implantable cardioverter-defibrillator, Angina, Myocardial infarction and Clinical trial are all subjects of inquiry into Internal medicine.
His Cardiology study combines topics from a wide range of disciplines, such as Angiography and Proportional hazards model.
The various areas that Daniel B. Mark examines in his Heart failure study include Randomization, Sudden cardiac death and Intensive care medicine.
His research in Randomized controlled trial intersects with topics in Kidney disease, Quality of life, Ischemia and Revascularization.
His research integrates issues of Mace, Stenosis, Unstable angina and Chest pain in his study of Coronary artery disease.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
